Takeda Pharmaceutical: First quarter financial report for the March 2025 period (IFRS) (consolidated).
Takeda Pharmaceutical: Extraordinary Report
Takeda Pharmaceutical: Confirmatory letter.
Takeda Pharmaceutical: Financial Report - 147th Term (2023/04/01 - 2024/03/31)
Takeda Pharmaceutical: (Correction) Partial revisions to financial results summary [IFRS] (consolidated) for the fiscal year ending March 31, 2024
Takeda Pharmaceutical: Notice regarding differences between full-year consolidated earnings forecasts and actual values for the fiscal year ending March 31, 2024
Takeda Pharmaceutical: Summary of financial results for the fiscal year ending 2024/3 [IFRS] (consolidated)
Takeda Pharmaceutical: Quarterly Report - 147th Quarter (2023/10/01 - 2023/12/31)
Takeda Pharmaceutical: Confirmation letter
Takeda Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/3 [IFRS] (consolidated)
Takeda Pharmaceutical: Confirmation letter
Takeda Pharmaceutical: Quarterly Report - 147th Second Quarter (2023/07/01 - 2023/09/30)
Takeda Pharmaceutical: Notice regarding revisions to full-year earnings forecasts (IFRS)
Takeda Pharmaceutical: Summary of Financial Results for the 2nd Quarter Ending March 2024 [IFRS] (consolidated)
Takeda Pharmaceutical: Confirmation letter
Takeda Pharmaceutical: Quarterly Report - First Quarter 147th (2023/04/01 - 2023/06/30)
Takeda Pharmaceutical: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [IFRS] (Consolidated)
Takeda Pharmaceutical: Extraordinary Report
Takeda Pharmaceutical: Confirmation letter
Takeda Pharmaceutical: Securities Report - 146th Period (2022/04/01 - 2023/03/31)
No Data
No Data